GTS NEWS
Friday, October 12, 2018
BREAKTHROUGH - It is being called a breakthrough for migraine suffers. A new FDA approved treatment called Emgality is the third in a class of new drugs that aim to stop the headaches before they begin.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment